Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 8—August 2018

Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea

Joon Kee Lee1, Joon Ho Lee1, Hyunju Lee, Young Min Ahn, Byung Wook Eun, Eun Young Cho, Hwa Jin Cho, Ki Wook Yun, Hoan Jong Lee, and Eun Hwa ChoiComments to Author 
Author affiliations: Seoul National University College of Medicine, Seoul, South Korea (J.K. Lee, J.H. Lee, H. Lee, E.Y. Cho, K.W. Yun, H.J. Lee, E.H. Choi); Seoul National University Children’s Hospital, Seoul (J.K. Lee, K.W. Yun, H.J. Lee, E.H. Choi); Kangwon National University School of Medicine, Chuncheon, South Korea (J.H. Lee); Seoul National University Bundang Hospital, Seongnam, South Korea (H. Lee); Eulji University School of Medicine, Daejeon, South Korea (Y.M. Ahn, B.W. Eun); Chungnam National University College of Medicine, Daejeon (E.Y. Cho); Chonnam National University Medical School, Gwangju, South Korea (H.J. Cho); Chonnam National University Children's Hospital, Gwangju (H.J. Cho)

Main Article

Table 3

Distribution of macrolide susceptibility within Mycoplasma pneumoniae sequence type 3, South Korea, 2000–2016

Macrolide susceptibility
Epidemic years, no. (%) strains
Susceptible 18 (100) 6 (100) 21 (95.5) 4 (17.4) 2 (5.0)

1 (4.5)
19 (82.6)
38 (95.0)
Total 18 6 22 23 40

Main Article

1These authors contributed equally to this article.

Page created: July 18, 2018
Page updated: July 18, 2018
Page reviewed: July 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.